Life Sciences | Deloitte Luxembourg has been added to your bookmarks.
Life Sciences companies continue to respond to a changing global landscape, and strive to pursue innovative solutions to address today's challenges. The DTTL network understands the complexity of these challenges, and works with clients worldwide to drive progress and bring discoveries to life.
2018 Global life sciences and health care outlooks
What trends will impact the patient’s journey of care in the year ahead?
With increasing industrialization, life sciences and health care companies are adopting emerging technologies to develop ‘smart health care’ and improve the overall patient experience. These increased capabilities, while leading to growth, are also leading to constant evolution of regulatory policies, and other uncertainties in the marketplace. The 2018 outlooks explore factors that are likely to shape the life sciences and health care industry in the coming year and beyond.
The future awakens
Life Sciences and Health Care Predictions 2022
The year is 2022. The quantified self is alive and well, digital technologies have transformed the culture of health care and new entrants have disrupted delivery models. This report from Deloitte UK's Centre for Health Solutions offers some predictions that, if they come true, will shake up the life sciences and health care industry in the next five years.
A new future for R&D?
Measuring the return from pharmaceutical innovation 2017
The pharmaceutical industry continues to face an extremely challenging R&D environment and has yet to turn a corner in terms of its R&D value proposition. Despite this, the Deloitte UK's report presents an optimistic road ahead for R&D and business leaders, exploring the emerging technologies that have the potential to dramatically transform the productivity and efficiency by which drugs are discovered, developed and brought to patients.